BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25806243)

  • 1. Molecular determinants of lung cancer metastasis to the central nervous system.
    Whitsett TG; Inge LJ; Dhruv HD; Cheung PY; Weiss GJ; Bremner RM; Winkles JA; Tran NL
    Transl Lung Cancer Res; 2013 Aug; 2(4):273-83. PubMed ID: 25806243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non-Small Cell Lung Cancer.
    Ahluwalia MS; Becker K; Levy BP
    Oncologist; 2018 Oct; 23(10):1199-1209. PubMed ID: 29650684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNS metastasis: an old problem in a new guise.
    Aragon-Ching JB; Zujewski JA
    Clin Cancer Res; 2007 Mar; 13(6):1644-7. PubMed ID: 17363516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain metastasis in lung cancer: Building a molecular and systems-level understanding to improve outcomes.
    Ebben JD; You M
    Int J Biochem Cell Biol; 2016 Sep; 78():288-296. PubMed ID: 27474492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis.
    Pedrosa RMSM; Mustafa DAM; Aerts JGJV; Kros JM
    Front Oncol; 2018; 8():159. PubMed ID: 29868480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis.
    Altundag K; Bondy ML; Mirza NQ; Kau SW; Broglio K; Hortobagyi GN; Rivera E
    Cancer; 2007 Dec; 110(12):2640-7. PubMed ID: 17960791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Modeling and Therapeutic Avenues for Cancer Metastasis to the Central Nervous System.
    Singh M; Bakhshinyan D; Venugopal C; Singh SK
    Front Oncol; 2017; 7():220. PubMed ID: 28971065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luminal subtypes predict improved survival following central nervous system metastasis in patients with surgically managed metastatic breast carcinoma.
    Wiens AL; Martin SE; Bertsch EC; Vance GH; Stohler RA; Cheng L; Badve S; Hattab EM
    Arch Pathol Lab Med; 2014 Feb; 138(2):175-81. PubMed ID: 24476516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CNS metastases in non-small-cell lung cancer: current role of EGFR-TKI therapy and future perspectives.
    Berger LA; Riesenberg H; Bokemeyer C; Atanackovic D
    Lung Cancer; 2013 Jun; 80(3):242-8. PubMed ID: 23453646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical approaches to study the biology and treatment of brain metastases.
    Cruz-Muñoz W; Kerbel RS
    Semin Cancer Biol; 2011 Apr; 21(2):123-30. PubMed ID: 21147227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-angiogenetic therapies for central nervous system metastases from non-small cell lung cancer.
    Buttigliero C; Bertaglia V; Novello S
    Transl Lung Cancer Res; 2016 Dec; 5(6):610-627. PubMed ID: 28149756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Targeting of the Premetastatic Stage in Human Lung-to-Brain Metastasis.
    Singh M; Venugopal C; Tokar T; McFarlane N; Subapanditha MK; Qazi M; Bakhshinyan D; Vora P; Murty NK; Jurisica I; Singh SK
    Cancer Res; 2018 Sep; 78(17):5124-5134. PubMed ID: 29986997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a preclinical model of spontaneous human melanoma central nervous system metastasis.
    Cruz-Munoz W; Man S; Xu P; Kerbel RS
    Cancer Res; 2008 Jun; 68(12):4500-5. PubMed ID: 18559492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer.
    Le Rhun E; Bertrand N; Dumont A; Tresch E; Le Deley MC; Mailliez A; Preusser M; Weller M; Revillion F; Bonneterre J
    Eur J Cancer; 2017 Dec; 87():189-198. PubMed ID: 29103666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of brain metastases in the modern genomic era.
    Dagogo-Jack I; Gill CM; Cahill DP; Santagata S; Brastianos PK
    Pharmacol Ther; 2017 Feb; 170():64-72. PubMed ID: 27773784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital PCR-Based Detection of EGFR Mutations in Paired Plasma and CSF Samples of Lung Adenocarcinoma Patients with Central Nervous System Metastases.
    Huang R; Xu X; Li D; Chen K; Zhan Q; Ge M; Zhou X; Liang X; Guan M
    Target Oncol; 2019 Jun; 14(3):343-350. PubMed ID: 31161597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology of brain metastasis.
    Svokos KA; Salhia B; Toms SA
    Int J Mol Sci; 2014 May; 15(6):9519-30. PubMed ID: 24879524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
    Bedikian AY; Wei C; Detry M; Kim KB; Papadopoulos NE; Hwu WJ; Homsi J; Davies M; McIntyre S; Hwu P
    Am J Clin Oncol; 2011 Dec; 34(6):603-10. PubMed ID: 21150567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastasis to the central nervous system from colorectal cancer.
    Chyun Y; Hayward E; Lokich J
    Med Pediatr Oncol; 1980; 8(3):305-8. PubMed ID: 7464689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.
    Bendell JC; Domchek SM; Burstein HJ; Harris L; Younger J; Kuter I; Bunnell C; Rue M; Gelman R; Winer E
    Cancer; 2003 Jun; 97(12):2972-7. PubMed ID: 12784331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.